6 research outputs found
N-terminal myristoylation is required for membrane localization of cGMP-dependent protein kinase type II
The apical membrane of intestinal epithelial cells harbors a unique
isozyme of cGMP-dependent protein kinase (cGK type II) which acts as a key
regulator of ion transport systems, including the cystic fibrosis
transmembrane conductance regulator (CFTR)-chloride channel. To explore
the mechanism of cGK II membrane-anchoring, recombinant cGK II was
expressed stably in HEK 293 cells or transiently in COS-1 cells. In both
cell lines, cGK II was found predominantly in the particulate fraction.
Immunoprecipitation of solubilized cGK II did not reveal any other tightly
associated proteins, suggesting a membrane binding motif within cGK II
itself. The primary structure of cGK II is devoid of hydrophobic
transmembrane domains; cGK II does, however, contain a penultimate
glycine, a potential acceptor for a myristoyl moiety. Metabolic labeling
showed that cGK II was indeed able to incorporate [3H]myristate. Moreover,
incubation of cGK II-expressing 293 cells with the myristoylation
inhibitor 2-hydroxymyristic acid (1 mM) significantly increased the
proportion of cGK II in the cytosol from 10 +/- 5 to 35 +/- 4%.
Furthermore, a nonmyristoylated cGK II Gly2 --> Ala mutant was localized
predominantly in the cytosol after transient expression in COS-1 cells.
The absence of the myristoyl group did not affect the specific enzyme
activity or the Ka for cGMP and only slightly enhanced the thermal
stability of cGK II. These results indicate that N-terminal myristoylation
fulfills a crucial role in directing cGK II to the membrane
A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbal ventral root avulsion and implantation.
Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system.
BACKGROUND: After a spinal cord lesion, axon regeneration is inhibited by the presence of a diversity of inhibitory molecules in the lesion environment. At and around the lesion site myelin-associated inhibitors, chondroitin sulfate proteoglycans (CSPGs) and several axon guidance molecules, including all members of the secreted (class 3) Semaphorins, are expressed. Interfering with multiple inhibitory signals could potentially enhance the previously reported beneficial effects of blocking single molecules. RNA interference (RNAi) is a tool that can be used to simultaneously silence expression of multiple genes. In this study we aimed to employ adeno-associated virus (AAV) mediated expression of short hairpin RNAs (shRNAs) to target all Semaphorin class 3 signaling by knocking down its receptors, Neuropilin 1 (Npn-1) and Neuropilin 2 (Npn-2). RESULTS: We have successfully generated shRNAs that knock down Npn-1 and Npn-2 in a neuronal cell line. We detected substantial knockdown of Npn-2 mRNA when AAV5 viral vector particles expressing Npn-2 specific shRNAs were injected in dorsal root ganglia (DRG) of the rat. Unexpectedly however, AAV1-mediated expression of Npn-2 shRNAs and a control shRNA in the red nucleus resulted in an adverse tissue response and neuronal degeneration. The observed toxicity was dose dependent and was not seen with control GFP expressing AAV vectors, implicating the shRNAs as the causative toxic agents. CONCLUSIONS: RNAi is a powerful tool to knock down Semaphorin receptor expression in neuronal cells in vitro and in vivo. However, when shRNAs are expressed at high levels in CNS neurons, they trigger an adverse tissue response leading to neuronal degradation
Meningeal cell-derived semaphorin 3A inhibits neurite outgrowth
The neural scar that forms after injury to the mammalian central nervous system is a barrier to sprouting and regenerating axons. In addition to reactive astrocytes that are present throughout the lesion site, leptomeningeal fibroblasts invade the lesion core. When isolated in vitro, these cells form a very poor substrate for growing neurites, even more so than reactive astrocytes. Nevertheless the molecular mechanisms involved in this growth inhibition are not well understood. Semaphorins have been reported to be upregulated in meningeal cells (MCs) on mechanical injury to the brain and spinal cord. In the present study, we show that Sema3A mRNA and active protein are produced by cultured meningeal cells. A protein extract from these cells induces the collapse of embryonic dorsal root ganglion (DRG) growth cones. This collapsing activity is partially blocked by neuropilin-1 antibodies and is absent in meningeal cells derived from Sema3A-knockout mice. In addition to growth cone collapse, recombinant Sema3A but not Sema3C inhibits neurite outgrowth of embryonic DRGs. Consistent with this result we find that the inhibitory effect of meningeal cells on neurite outgrowth is partially overcome on Sema3A-deficient MCs. Furthermore we show that the inhibitory effect of MC-derived Sema3A on neurite outgrowth is modulated by nerve growth factor. Our results show that Sema3A, a chemorepellent during nervous system development, is a major neurite growth-inhibitory molecule in meningeal fibroblasts and is therefore likely to contribute to the inhibitory properties of the neural scar
Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors.
The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain
Scientific Assessment and Innovation in Neurosurgical Treatment Strategie